BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 4, 2013
View Archived Issues
Charleston Laboratories completes phase III trial of CL-108 at the midway point
Read More
Chugai Pharmaceutical presents highlights of third quarter 2013
Read More
Mayo Clinic and Mayo Medical Laboratories to offer bioTheranostics' CancerTYPE ID test
Read More
AstraZeneca begins phase III benralizumab program in severe asthma
Read More
Lurbinectedin shows promise in phase Ib lung cancer trials
Read More
Numab reacquires ND-003 from Sucampo Pharmaceuticals
Read More
Gates Foundation enters Vaccine Discovery Partnerships with GSK and Sanofi Pasteur
Read More
Hanmi's HM-61713 effective in phase I NSCLC trial
Read More
Merck Serono expands two collaborations
Read More
IncellDx and Bristol-Myers to develop assay for companion diagnostic test
Read More
First phase II results reported for MLN-8237 in SCLC
Read More
Xoma reports results from two phase II studies in proof-of-concept program for gevokizumab
Read More
Mitsubishi Tanabe provides update on product development in second quarter of 2013
Read More
Targeting siglec-15 with an antibody reduces bone loss in ovariectomized rats
Read More
Anti-sclerostin monoclonal antibody shows promise in phase IIa hypophosphatasia trial
Read More
Model used to predict increase in bone mineral density with DS-9194b
Read More
Integrated Diagnostics presents new lung blood test
Read More
Phase II trial of Cornerstone Pharmaceuticals' CPI-613 in pancreatic cancer begins
Read More
Novartis files petition with the FDA regarding naming policy for biosimilars
Read More
Ariad Pharmaceuticals temporarily suspends sales of ponatinib at request of FDA
Read More
Baxter submits MAA to EMA for Rixubis
Read More
Synergy Pharmaceuticals starts phase II study of SP-333 for OIC
Read More
SymBio and Eisai discontinue Japanese phase II trial of Treakisym
Read More
Glenmark Pharmaceuticals patents new ITK inhibitors
Read More
Japanese researchers disclose new alpha7 receptor positive allosteric modulators
Read More
New GTPas KRas inhibitors for cancer presented by the University of California
Read More
FDA approves Gazyva for previously untreated chronic lymphocytic leukemia
Read More